Morphine buccal - Generex Biotechnology

Drug Profile

Morphine buccal - Generex Biotechnology

Alternative Names: Morphine oral spray - Generex

Latest Information Update: 10 Jan 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Generex Biotechnology Corporation
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 11 Sep 2013 Biomarkers information updated
  • 10 Jan 2013 Morphine buccal is available for licensing as of 10 Jan 2013. http://www.generex.com/
  • 31 Jul 2009 No development reported - Phase-I for Pain in Canada (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top